|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34,900 KRW | +0.72% |
|
+10.27% | +129.45% |
Verismo Therapeutics, Inc. announced that it will issue 3,187,962 common shares at a price of KRW 3,807.56400013551 for gross proceeds of KRW 12,138,369,345 on April 6, 2022. The transaction will involve participation from HLB Pharmaceutical Co., Ltd. The transaction will take place through third party allotment. The transaction is expected to close on April 8, 2022.
The transaction has been approved by the shareholders.
| 1st Jan change | Capi. | |
|---|---|---|
| +129.45% | 356M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
HLB PHARMACEUTICAL CO., LTD. 
